Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Clinical Breast Cancer|May 14, 2004
Use of trastuzumab beyond disease progression: observations from a retrospective review of case historiesKaren A Gelmon, John Mackey, Shailendra Verma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2007
Class III beta-tubulin expression and benefit from adjuvant cisplatin/vinorelbine chemotherapy in operable non-small cell lung cancer: analysis of NCIC JBR.10Pascal Sève, Raymond Lai, Keyue Ding, et al.
Scientific Reports|November 8, 2016
Insights into a novel nuclear function for Fascin in the regulation of the amino-acid transporter SLC3A2Amine Saad, Krikor Bijian, Dinghong Qiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trialJudith Hugh, John Hanson, Maggie Chon U Cheang, et al.
Oncogene|November 22, 2018
Oncogenic activity of poly (ADP-ribose) glycohydrolaseMaud Marques, Maika Jangal, Li-Chun Wang, et al.
Cardiovascular Research|April 18, 2015
PKCε-CREB-Nrf2 signalling induces HO-1 in the vascular endothelium and enhances resistance to inflammation and apoptosisHayley Mylroie, Odile Dumont, Andrea Bauer, et al.
Current Cancer Drug Targets|June 29, 2010
Human equilibrative nucleoside transporter 1 (hENT1) levels predict response to gemcitabine in patients with biliary tract cancer (BTC)Daniele Santini, Gaia Schiavon, Bruno Vincenzi, et al.
The Journal of Biological Chemistry|August 14, 2015
Modulator of apoptosis 1 (MOAP-1) is a tumor suppressor protein linked to the RASSF1A proteinJennifer Law, Mohamed Salla, Alaa Zare, et al.
International Journal of Cancer|June 9, 2025
Safety and efficacy of docosahexaenoic acid supplementation during neoadjuvant breast cancer therapy: Findings from the phase II, double-blind, randomized controlled DHA-WIN trialJaqueline Munhoz, Marnie Newell, Gilbert Bigras, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2015
PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab ResistanceHoward M Stern, Humphrey Gardner, Tomasz Burzykowski, et al.
Pageof 5